文献速递肾癌与肾肿瘤

肾肿瘤大小与侵袭性组织学概率:对监测和治疗决策的意义

The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
PubMed 文献 · Eur Urol · 2018-07-13

该研究基于1990–2010年在Mayo Clinic接受肾切除或部分肾切除的2650例pT1-2、pNx/0、M0实体肾肿瘤患者,由单一泌尿生殖病理学家复核病理,按肿瘤大小和性别估算恶性及侵袭性组织学的概率。结果显示2cm、3cm、4cm肿瘤的恶性概率分别为84%、87%、88%,侵袭性组织学概率分别为18%、24%、29%;惰性恶性肿瘤10年癌症特异性生存率为96%,侵袭性恶性肿瘤为81%。

要点

  • 肿瘤越大,恶性和侵袭性组织学概率越高。
  • 2–4cm肿瘤侵袭性组织学概率为18%–29%。
  • 相同大小下男性侵袭性组织学概率高于女性。

核心结论

  • 基于肿瘤大小可估算肾肿块为恶性及侵袭性组织学的概率,有助于初始患者咨询和管理决策。

研究设计与样本

  • 回顾性观察性手术队列,纳入1990–2010年Mayo Clinic接受肾切除或部分肾切除的2650例pT1-2、pNx/0、M0实体肾肿瘤患者,病理由单一泌尿生殖病理学家复核。

主要发现

  • 2650例中惰性肿瘤1860例(良性300例,恶性1560例),侵袭性肿瘤790例。
  • 惰性恶性肿瘤10年癌症特异性生存率为96%,侵袭性恶性肿瘤为81%。
  • 2cm、3cm、4cm肿瘤的恶性概率分别为84%、87%、88%,侵袭性组织学概率分别为18%、24%、29%。
  • 对于任何给定肿瘤大小,男性侵袭性组织学概率高于女性。

关键数值与推荐

  • 侵袭性组织学定义为高级别透明细胞肾细胞癌、高级别乳头状肾细胞癌、集合管癌、易位相关肾细胞癌、遗传性平滑肌瘤病肾细胞癌、未分类肾细胞癌及恶性非肾细胞癌肿瘤,以及任何伴凝固性坏死(低级别乳头状肾细胞癌除外)或肉瘤样分化的肿瘤。
  • 其余良性和恶性肿瘤归为惰性。

临床怎么用

  • 肿瘤大小和性别可用于初始咨询时估算肾肿块为恶性及侵袭性组织学的概率,辅助监测或治疗决策。

局限性

  • 观察性手术队列存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While the probability of malignant versus benign histology based on renal tumor size has been described, this alone does not sufficiently inform decision-making in the modern era since indolent malignant tumors can be managed with active surveillance. OBJECTIVE: To characterize the probability of aggressive versus indolent histology based on radiographic tumor size. DESIGN, SETTING, AND PARTICIPANTS: We evaluated patients who underwent radical or partial nephrectomy at Mayo Clinic for a pT1-2, pNx/0, M0 solid renal tumor between 1990 and 2010. Pathology was reviewed by one genitourinary pathologist. High-grade clear-cell renal cell carcinoma (RCC), high-grade papillary RCC, collecting duct RCC, translocation-associated RCC, hereditary leiomyomatosis RCC, unclassified RCC, and malignant non-RCC tumors were all considered aggressive, as well as any tumors demonstrating coagulative necrosis (except low-grade papillary RCC) or sarcomatoid differentiation. The remaining benign and malignant tumors were considered indolent. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Cancer-specific survival (CSS) was estimated using the Kaplan-Meier method. Logistic regression models were used to estimate the probability of malignant and aggressive histology based on tumor size. Sex-stratified analyses were also performed. RESULTS AND LIMITATIONS: Of the 2650 patients included, there were 1860 patients with indolent tumors (300 benign; 1560 malignant) and 790 with aggressive tumors. The 10-yr CSS was 96% for indolent malignant tumors and 81% for aggressive malignant tumors. The predicted percentages of any malignant histology as well as aggressive histology increased with tumor size. Specifically, 2cm, 3cm, and 4cm tumors have an estimated 84%, 87%, and 88% likelihood of malignancy, respectively, and an 18%, 24%, and 29% likelihood of aggressive histology, respectively. For any given tumor size, men had a greater chance of aggressive histology than women. Potential limitations of this observational surgical cohort include selection bias. CONCLUSIONS: We present tumor size-based estimates of the probability of aggressive histology for renal masses. This information should be useful for initial patient counseling and management. PATIENT SUMMARY: Active surveillance is an option for kidney masses, even if they are malignant. Beyond knowing whether the mass is benign or cancer, it is important to know whether or not it is an aggressive tumor. This study presents tumor size-specific and sex-specific estimates of the probability of cancer overall and aggressive cancer among patients with a kidney mass in order to aid with initial decision-making.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Bhindi B, Thompson RH, Lohse CM, et al. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment. Eur Urol. 2018. PMID: 30017400. doi:10.1016/j.eururo.2018.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。